Moody’s also affirmed Doylestown’s “Baa2” ratings, affecting $60.6 million of rated debt. The rating affirmation is based on several factors, including Doylestown’s strong market position and proactive management team.
The rating revision is based on Doylestown’s recent weaker-than-expected operating performance, which exacerbates its investment losses.
More articles on healthcare finance:
Mercer Health plans $24M expansion
Indiana radiology group selects McKesson for RCM services
5 ways to build your case for inventory management technology
